why choose us

First received: May 15, 2023

Clinical Trial: Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in de Novo Metastatic to Lymph Nodes Prostate Cancer

Brief Summary: To learn about the effectiveness of adding talazoparib to the standard of care treatment combination of androgen ablation therapy (hormone therapy, also known as ADT) and enzalutamide in patients with prostate cancer that has spread into the lymph nodes.

Read more